Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (35)

2023

  1. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

    Respiratory Medicine

  2. Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis

    Biomedicines, Vol. 11, Núm. 7

  3. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  4. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2

  5. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  6. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease

    Genes, Vol. 13, Núm. 4

2021

  1. Genetics and Epigenetics of Nasal Polyposis: A Systematic Review

    Journal of investigational allergology & clinical immunology, Vol. 31, Núm. 3, pp. 196-211

  2. Increased TPSAB1 Copy Number in a Family With Elevated Basal Serum Levels of Tryptase

    Frontiers in Medicine, Vol. 8

  3. Polymorphisms in eicosanoid-related biosynthesis enzymes associated with acute urticaria/angioedema induced by nonsteroidal anti-inflammatory drug hypersensitivity

    British Journal of Dermatology, Vol. 185, Núm. 4, pp. 815-824

2020

  1. Atopy can be an interfering factor in genetic association studies of ß-lactam allergy

    Journal of Investigational Allergology and Clinical Immunology

  2. Genetics and epigenetics of atopic dermatitis: An updated systematic review

    Genes, Vol. 11, Núm. 4

  3. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Frontiers in Medicine, Vol. 7

  4. Promoter genotyping and mRNA expression– based analysis of the PTGDR gene in allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 2, pp. 117-126

2019

  1. Dupilumab in Atopic Dermatitis

    Current Treatment Options in Allergy, Vol. 6, Núm. 3, pp. 211-225

  2. PTGDR expression is upregulated through retinoic acid receptors (RAR) mechanism in allergy

    PLoS ONE, Vol. 14, Núm. 4

  3. YRNAs overexpression and potential implications in allergy

    World Allergy Organization Journal, Vol. 12, Núm. 8

2018

  1. Cluster Analysis Identifies 3 Phenotypes within Allergic Asthma

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, Núm. 3, pp. 955-961.e1

2017

  1. PTGDR gene expression and response to dexamethasone treatment in an in vitro model

    PLoS ONE, Vol. 12, Núm. 10

  2. Pharmacogenetics and the treatment of asthma

    Pharmacogenomics, Vol. 18, Núm. 13, pp. 1271-1280